Variably protease-sensitive prionopathy
| Variably protease-sensitive prionopathy | |
|---|---|
| Synonyms | |
| Pronounce | |
| Field | |
| Symptoms | Dementia, behavioral and psychiatric symptoms, ataxia, parkinsonism |
| Complications | |
| Onset | 70 years |
| Duration | |
| Types | |
| Causes | Prion |
| Risks | |
| Diagnosis | |
| Differential diagnosis | |
| Prevention | |
| Treatment | |
| Medication | |
| Prognosis | Average survival 24 months |
| Frequency | |
| Deaths | |
Variably protease-sensitive prionopathy (VPSPr) (formerly known as Protease Sensitive Prionopathy) is a sporadic prion protein disease first described in an abstract for a conference on prions in 2006, and this study was published in a 2008 report on 11 cases. The study was conducted by Gambetti P., Zou W.Q., and coworkers from the United States National Prion Disease Pathology Surveillance Center.<ref name="pmid18571782">,
A novel human disease with abnormal prion proteining sensitive to protease, Ann. Neurol., Vol. 63(Issue: 6), pp. 697–708, DOI: 10.1002/ana.21420, PMID: 18571782, PMC: 2767200,</ref><ref>
The Merck Manual - Variably Protease-Sensitive Prionopathy (VPSPr)(link). {{{website}}}. Merck Sharp & Dohme Corp., a subsidiary of Merck & Co..
</ref> It was first identified as a distinct disease in 2010 by Zou W.Q. and coworkers from the United States National Prion Disease Pathology Surveillance Center.<ref>,
Variably protease-sensitive prionopathy: A new sporadic disease of the prion protein, Annals of Neurology, 2010, Vol. 68(Issue: 2), pp. 162–172, DOI: 10.1002/ana.22094, PMID: 20695009, PMC: 3032610,</ref>
VPSPr is very rare, occurring in just 2 or 3 out of every 100 million people.<ref> ,
Variably Protease-Sensitive Prionopathy (VPSPr) - Neurologic Disorders - Merck Manuals Professional Edition Full text, Merck Manuals Professional Edition, Accessed on: 2018-03-04.
</ref> As of 2018, fourteen cases have been reported in the UK.<ref>
Creutzfeldt - Jakob disease in the UK (By calendar year)(link). '.
Accessed 4 July 2018.
</ref> It has similarities to Creutzfeldt–Jakob disease, but clinical manifestations differ somewhat, and the abnormal prion protein (PrP) is less resistant to digestion by proteases; some variants are more sensitive to proteases than others, hence the name: variably protease-sensitive.
Patients present with behavioral and psychiatric symptoms, speech deficits (aphasia and/or dysarthria) and progressive cognitive and motor decline (dementia, ataxia, parkinsonism, psychosis, aphasia and mood disorder). Average age at onset is 70 years, and duration of survival is 24 months. About 40% of patients have a family history of dementia. Like CJD, it can be mistaken for Alzheimer's dementia.
Diagnosis is difficult, as pathognomonic signs on MRI such as cortical ribboning or hockey stick sign, periodic sharp wave complexes on EEG, and tests for 14-3-3 protein and tau protein are usually not helpful, and no mutations have been observed in the coding region of the PrP gene, unlike CJD and Variant CJD.<ref name="pmid18570344">,
A new prionopathy, Ann. Neurol., Vol. 63(Issue: 6), pp. 677–8, DOI: 10.1002/ana.21447, PMID: 18570344,</ref> The diagnosis can be made on pathological examination. There are unique microscopic and immunohistochemical features, and the prions cannot be digested using proteases. Because 8 out of 10 patients had a positive family history of dementia in the original study, a genetic cause was suspected.
Some have suggested the disease may be a sporadic form of GSS.<ref>,
Variable Protease-Sensitive Prionopathy Transmission to Bank Voles, Emerging Infectious Diseases, 2019, Vol. 25, pp. 73–81, DOI: 10.3201/eid2501.180807, PMC: 6302590,</ref>
See also
References
<references group="" responsive="1"></references>
External links
Caroline Parkinson. Brain disease could affect more people, research finds(link). {{{website}}}. BBC News. 13 August 2010.
| Prion diseases and transmissible spongiform encephalopathy | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Portions of content adapted from Wikipedia's article on Variably protease-sensitive prionopathy which is released under the CC BY-SA 3.0.
| This article is a stub. You can help WikiMD by registering to expand it. |
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
